Cargando…

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426386/ http://dx.doi.org/10.1007/s40278-020-82172-6

Ejemplares similares

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021)

Tocilizumab: Bowel perforation following off-label use: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Methylprednisolone: Fungaemia following an off-label use: case report
Publicado: (2022)

Tocilizumab: Acute terminal ileum and perforated caecal ulceration following off label use: case report
Publicado: (2020)

Dexamethasone/prednisolone/tocilizumab: Gastrointestinal perforation and off-label use: 3 case reports
Publicado: (2022)

Immune-globulin/methylprednisolone/tocilizumab: Lack of response following off-label use in SARS-CoV-2 infection: case report
Publicado: (2021)

Azithromycin/methylprednisolone: Hyperglycaemia following off label use: case report
Publicado: (2020)

Methylprednisolone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021)

Methylprednisolone: Strongyloidiasis following off-label treatment: case report
Publicado: (2022)

Methylprednisolone: Decrease in T cell count following off label use: case report
Publicado: (2020)

Methylprednisolone: Rhino-facial mucormycosis following off label use: case report
Publicado: (2022)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)

Tocilizumab: Lobar pneumonia following off label use: case report
Publicado: (2020)

Tocilizumab: Bacterial superinfection following off-label use: case report
Publicado: (2020)

Tocilizumab: Anastomotic leakage following off label use: case report
Publicado: (2021)

Tocilizumab: Active tuberculosis following off label use: case report
Publicado: (2021)

Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021)

Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022)

Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone: Osteonecrosis of the knee following off-label use: 2 case reports
Publicado: (2022)

Hydroxyzine/methylprednisolone/pheniramine: Lack of efficacy following off label use : case report
Publicado: (2022)

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Tocilizumab: Decrease in WBC count following an off-label use: case report
Publicado: (2020)

Tocilizumab: Progression of multiple myeloma following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c2pmum9t1i0eghsluthq4pb359